Recent Submissions

  • Collaborating with youth to inform and develop tools for psychotropic decision making 

    Murphy, A., D. Gardner, S. Kutcher, S. Davidson, et al. 2010. "Collaborating with youth to inform and develop tools for psychotropic decision making." Journal of the Canadian Academy of Child and Adolescent Psychiatry 19(4): 256-263.
    Introduction: Youth oriented and informed resources designed to support psychopharmacotherapeutic decision-making are essentially unavailable. This article outlines the approach taken to design such resources, the product ...
  • Psychopharmacological treatment options for global child and adolescent mental health: The WHO essential medicines lists 

    Kutcher, S., A. Murphy, and D. Gardner. 2008. "Psychopharmacological treatment options for global child and adolescent mental health: The WHO essential medicines lists." Journal of the American Academy of Child and Adolescent Psychiatry 47(10): 1105-1113.
    No abstract available.
  • Drug information resources used by nurse practitioners and collaborating physicians at the point of care in Nova Scotia, Canada: A survey and review of the literature 

    Murphy, A. L., M. Fleming, R. Martin-Misener, I. S. Sketris, et al. 2006. "Drug information resources used by nurse practitioners and collaborating physicians at the point of care in Nova Scotia, Canada: A survey and review of the literature." BMC Nursing 5.
    Background: Keeping current with drug therapy information is challenging for health care practitioners. Technologies are often implemented to facilitate access to current and credible drug information sources. In the ...
  • Prescribing trends of antipsychotics in youth receiving income assistance: Results from a retrospective population database study 

    Murphy, A. L., D. M. Gardner, C. Cooke, S. Kisely, et al. 2013. "Prescribing trends of antipsychotics in youth receiving income assistance: Results from a retrospective population database study." BMC Psychiatry 13.
    Background: Prescribing of antipsychotics (AP) to young people has increased in the last decade internationally. We aimed to characterize AP prescribing in a population of low-income youth in Nova Scotia, Canada.Methods: ...
  • Phenytoin-diazepam interaction 

    Murphy, A., and K. Wilbur. 2003. "Phenytoin-diazepam interaction." Annals of Pharmacotherapy 37(5): 659-663.
    OBJECTIVE: To report a case of phenytoin toxicity potentially associated with concurrent diazepam therapy. CASE SUMMARY: A 44-year-old First Nations man presented to the emergency department with headache, nystagmus, ...
  • Administrative claims data analysis of nurse practitioner prescribing for older adults 

    Murphy, A. L., R. Martin-Misener, C. Cooke, and I. Sketris. 2009. "Administrative claims data analysis of nurse practitioner prescribing for older adults." Journal of advanced nursing 65(10): 2077-2087.
    Aim. This paper is a report of a study to identify the patterns of prescribing by primary health care nurse practitioners for a cohort of older adults. Background. The older adult population is known to receive complex ...
  • Pharmacists' participation in an inhaled respiratory medication program: Reimbursement of professional fees 

    Murphy, AL, NJ MacKinnon, PS Flanagan, SK Bowles, et al. 2005. "Pharmacists' participation in an inhaled respiratory medication program: Reimbursement of professional fees." Annals of Pharmacotherapy 39(4): 655-661.
    BACKGROUND: An intervention (termed Initiative) was initiated to facilitate converting beneficiaries of a public drug insurance program in the province of Nova Scotia from respiratory nebulization medications to inhalers. ...
  • Evidence review and clinical guidance for the use of ziprasidone in Canada 

    Gardner, D. M., A. L. Murphy, S. Kutcher, S. Beaulieu, et al. 2013. "Evidence review and clinical guidance for the use of ziprasidone in Canada." Annals of General Psychiatry 12(1).
    While indicated for schizophrenia and acute mania, ziprasidone's evidence base and use in clinical practice extends beyond these regulatory approvals. We, an invited panel of experts led by a working group of 3, critically ...
  • International consensus study of antipsychotic dosing 

    Gardner, D. M., A. L. Murphy, H. O'Donnell, F. Centorrino, et al. 2010. "International consensus study of antipsychotic dosing." American Journal of Psychiatry 167(6): 686-693.
    Objective: Potency equivalents for antipsychotic drugs are required to guide clinical dosing and for designing and interpreting research studies. Available dosing guidelines are limited by the methods and data from which ...
  • Community pharmacist services for people with mental illnesses: Preferences, satisfaction, and stigma 

    Black, E., A. L. Murphy, and D. M. Gardner. 2009. "Community pharmacist services for people with mental illnesses: Preferences, satisfaction, and stigma." Psychiatric Services 60(8): 1123-1127.
    Objective: The aim of this study was to determine patient preferences, satisfaction, and perceived stigma related to community pharmacists. Methods: A total of 79 persons receiving psychotropic medications from community ...
  • Policy choices for pharmacare; the need to examine benefit design, medication management strategies and evaluation. 

    Sketris, I. S., M. G. Brown, and A. L. Murphy. 2004. "Policy choices for pharmacare; the need to examine benefit design, medication management strategies and evaluation.." HealthcarePapers 4(3): 36-45.
    Outside hospitals, drug therapy is not universally insured by the Canadian public health care system. Coverage depends on choices made by the provincial and territorial governments in designing their pharmacare programs. ...